Advice
Following a full submission:
budesonide gastro-resistant capsule (Budenofalk®) is accepted for use within NHS Scotland.
Indication under review: symptomatic relief of chronic diarrhoea due to collagenous colitis.
budesonide (Budenofalk®) provides symptomatic improvement of diarrhoea associated with collagenous colitis compared with placebo.
Download detailed advice122KB (PDF)
Medicine details
- Medicine name:
- budesonide 3mg gastro-resistant capsule (Budenofalk)
- SMC ID:
- 828/12
- Indication:
- For the symptomatic relief of chronic diarrhoea due to collagenous colitis.
- Pharmaceutical company
- Dr Falk Pharma UK
- BNF chapter
- Gastro-intestinal system
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 14 January 2013